These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment. Fabbri C; Porcelli S; Serretti A Can J Psychiatry; 2014 Feb; 59(2):62-75. PubMed ID: 24881125 [TBL] [Abstract][Full Text] [Related]
27. Lithium long-term treatment in mood disorders: clinical and genetic predictors. Serretti A Pharmacogenomics; 2002 Jan; 3(1):117-29. PubMed ID: 11966408 [TBL] [Abstract][Full Text] [Related]
28. The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments. Serretti A; Benedetti F; Zanardi R; Smeraldi E Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1074-84. PubMed ID: 15939518 [TBL] [Abstract][Full Text] [Related]
29. Affective disorder and epilepsy comorbidity: implications for development of treatments, preventions and diagnostic approaches. Jobe PC Clin EEG Neurosci; 2004 Jan; 35(1):53-68. PubMed ID: 15112464 [TBL] [Abstract][Full Text] [Related]
30. Pharmacogenomics of antidepressant induced mania: a review and meta-analysis of the serotonin transporter gene (5HTTLPR) association. Biernacka JM; McElroy SL; Crow S; Sharp A; Benitez J; Veldic M; Kung S; Cunningham JM; Post RM; Mrazek D; Frye MA J Affect Disord; 2012 Jan; 136(1-2):e21-e29. PubMed ID: 21680025 [TBL] [Abstract][Full Text] [Related]
31. Genome-wide association studies in pharmacogenomics of antidepressants. Lin E; Lane HY Pharmacogenomics; 2015; 16(5):555-66. PubMed ID: 25916525 [TBL] [Abstract][Full Text] [Related]
32. Molecular genetics of bipolar disorder and depression. Kato T Psychiatry Clin Neurosci; 2007 Feb; 61(1):3-19. PubMed ID: 17239033 [TBL] [Abstract][Full Text] [Related]
33. Genetics and personalized medicine in antidepressant treatment. Gvozdic K; Brandl EJ; Taylor DL; Müller DJ Curr Pharm Des; 2012; 18(36):5853-78. PubMed ID: 22681166 [TBL] [Abstract][Full Text] [Related]
34. [Current state and potential of pharmacogenetic studies in the treatment of depression]. Ivanets NN; Tikhonova YG; Kinkulkina MA; Avdeeva TI Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(3):113-121. PubMed ID: 26171487 [TBL] [Abstract][Full Text] [Related]
35. Drugs, genes and the blues: pharmacogenetics of the antidepressant response from mouse to man. O'Leary OF; O'Brien FE; O'Connor RM; Cryan JF Pharmacol Biochem Behav; 2014 Aug; 123():55-76. PubMed ID: 24161683 [TBL] [Abstract][Full Text] [Related]
36. Predicting response to lithium in mood disorders: role of genetic polymorphisms. Serretti A; Artioli P Am J Pharmacogenomics; 2003; 3(1):17-30. PubMed ID: 12562213 [TBL] [Abstract][Full Text] [Related]
39. Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research. Fabbri C; Di Girolamo G; Serretti A Am J Med Genet B Neuropsychiatr Genet; 2013 Sep; 162B(6):487-520. PubMed ID: 23852853 [TBL] [Abstract][Full Text] [Related]
40. [Mechanism of action of antidepressants and therapeutic perspectives]. Bourin M; David DJ; Jolliet P; Gardier A Therapie; 2002; 57(4):385-96. PubMed ID: 12422559 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]